Envelope protein-targeted vaccines for flaviviruses are restricted by considerations of antibody-dependent enhancement (ADE) of infections. Nonstructural protein 1 (NS1) supplies an alternate vaccine goal that avoids this danger since this
Envelope protein-targeted vaccines for flaviviruses are restricted by considerations of antibody-dependent enhancement (ADE) of infections. Nonstructural protein 1 (NS1) supplies an alternate vaccine goal that avoids this danger since this
Bispecific antibodies (bsAbs) are thought of as an essential class of biopharmaceutical medicine, with about 160 merchandise in scientific trials. From an analytical standpoint, the right chain-association is likely one